Clinical Trial Update: Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

This report covers a Phase 1/Phase 2 clinical trial evaluating aliskiren, irbesartan, and their combination in hypertensive patients with type 2 diabetes and di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aliskiren (Aliskiren)
• Aliskiren/Irbesartan combination
• Irbesartan (irbesartan)

Snippet

Sponsor: Novartis | Conditions: Diabetes Type 2 | Phase 1, Phase 2 | Status: COMPLETED